title: VKORC1 and CYP2C9 genetic polymorphisms in hepatic or portal vein thrombosis.
authors.affiliation: Department of Haematology, Beaujon hospital, AP-HP, Clichy, France. eric.pasmant@bjn.aphp.fr
authors.forename: Eric
authors.initials: E
authors.lastname: Pasmant
authors.forename: Charlotte
authors.initials: C
authors.lastname: de Beauvoir
authors.forename: Aurélie
authors.initials: A
authors.lastname: Plessier
authors.forename: Julien
authors.initials: J
authors.lastname: Labreuche
authors.forename: Annie
authors.initials: A
authors.lastname: Bezeaud
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics*; D006502:Budd-Chiari Syndrome / Q000188:drug therapy / Q000235:genetics*; D015331:Cohort Studies; D065729:Cytochrome P-450 CYP2C9; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D006899:Mixed Function Oxygenases / Q000235:genetics*; D011110:Polymorphism, Genetic; D014812:Vitamin K / Q000037:antagonists & inhibitors; D064417:Vitamin K Epoxide Reductases
chemical_list: D000925:Anticoagulants; D014812:Vitamin K; D006899:Mixed Function Oxygenases; C450260:CYP2C9 protein, human; D065729:Cytochrome P-450 CYP2C9; D001189:Aryl Hydrocarbon Hydroxylases; C578523:VKORC1 protein, human; D064417:Vitamin K Epoxide Reductases